BEUDAMED
    FDA PMA FDA Class 3 Approved 🇺🇸 United States

    Reherniation Reduction Device

    PMA: P160050 · Supplement: S006 · Decision May 19, 2020
    View on FDA
    Classifications
    1
    FEI Numbers
    2
    Registration Numbers
    2

    Basic Information

    Device Name
    Reherniation Reduction Device
    Trade Name
    Barricaid Annular Closure Device
    PMA Number
    P160050
    Supplement Number
    S006
    Device Class
    FDA Class 3
    Product Code
    QES
    Generic Name
    Reherniation reduction device
    Medical Specialty
    Unknown
    Advisory Committee
    Orthopedic
    Decision
    Approved
    Decision Code
    APPR
    Decision Date
    May 19, 2020
    Date Received
    April 22, 2020
    Supplement Type
    Normal 180 Day Track No User Fee
    Supplement Reason
    Postapproval Study Protocol
    Expedited Review
    N

    Advisory Committee Statement

    Approval of the revised protocol for the post-approval study (PAS) protocol.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    QES Reherniation Reduction Device